Study of Difluprednate in the Treatment of Inflammation Following Ocular Surgery (ST-601A-002a)

NCT00429923 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

219

Enrollment

INDUSTRY

Sponsor class

Conditions

Inflammation

Interventions

DRUG: Difluprednate
DRUG: Difluprednate
DRUG: Placebo

Sponsor

Sirion Therapeutics, Inc.